1 terminated, 1 unknown. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Maxillofacial Injuries: new trials by email Literature Review of Maxillofacial Injuries trials Research Report on Maxillofacial Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction EB-CMF - Mandible Tumor, Mandibular Injuries | Phase 1 / Phase 2 | Unknown | Epibone, Inc. | 6 | 2021-03-31 | 2022-05-27 |
| The Evaluation of Postoperative Antibiotics in Non-Infected Mandible Fractures Antibiotic treatment (Unasyn or Cleocin), Antibiotic treatment (Augmentin or Cleocin), Control Group - Jaw Fractures, Infection | Phase 1 | Terminated | The University of Texas Health Science Center, Houston | 13 | 2020-10-01 | 2025-06-26 |
Congenital Abnormalities (1) · Infections (1) · Jaw Fractures (1) · Mandibular Injuries (1) · Mandibular Neoplasms (1)
Craniocerebral Trauma (2) · Facial Injuries (2) · Nervous System Diseases (2) · Trauma, Nervous System (2) · Wounds and Injuries (2) · Bone Diseases (1) · Bone Neoplasms (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Fractures, Bone (1) · Jaw Diseases (1) · Jaw Neoplasms (1) · Mandibular Diseases (1) · Musculoskeletal Diseases (1) · Neoplasms (1)
Amoxicillin-Potassium Clavulanate Combination (1) · Clindamycin (1) · Control Groups (1) · sultamicillin (1)
Epibone, Inc. (1) · The University of Texas Health Science Center, Houston (1)
United States (2)
Brian R Gastman, MD (1) · Nagi Demian, DDS/MD (1)